Gross Margin
-16.37%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -36.55%.Updated Sep 21, 2026Profit Margin
-10.30%vs Specialty Chemicals peers Updated Sep 21, 2026Operating Margin
-70.25%vs Specialty Chemicals peers Updated Sep 21, 2026Return on Assets (TTM)
-8.18%vs Specialty Chemicals peers Updated Sep 21, 2026Return on Equity (TTM)
-16.86%vs Specialty Chemicals peers Updated Sep 21, 2026Revenue (TTM)
503.26MCNY75.15M · vs all stocks (USD) Updated Sep 21, 2026Revenue per Share (TTM)
0.2420CNYUpdated Sep 21, 2026Quarterly Revenue Growth
28.70%vs Specialty Chemicals peers Updated Sep 21, 2026Gross Profit (TTM)
-183.96MCNY-27.47M · vs all stocks (USD) Updated Sep 21, 2026EBITDA (TTM)
219.24MCNY32.74M · vs all stocks (USD) Updated Sep 21, 2026Net Income (TTM)
-51.85MCNY-7.74M · vs all stocks (USD) Updated Sep 21, 2026Quarterly Earnings Growth (YoY)
67.04%vs Specialty Chemicals peers Updated Sep 21, 2026Operating Cash Flow (TTM)
-387.91MCNY-57.93M · vs all stocks (USD) Updated Sep 21, 2026Levered Free Cash Flow (TTM)
-1.49BCNY-222.62M · vs all stocks (USD) Updated Sep 21, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Sep 21, 2026Minority Interest (Equity)
128.07MCNYFY2025 · Dec 31, 2025Revenue
444.48MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
533.18MCNYFY2025 · Dec 31, 2025Gross Profit
-88.70MCNYFY2025 · Dec 31, 2025Operating Income
-202.01MCNY-30.17M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-157.98MCNYFY2025 · Dec 31, 2025Income Tax Expense
4.92MCNYFY2025 · Dec 31, 2025Net Income
-162.89MCNYFY2025 · Dec 31, 2025EBIT
-130.50MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
219.24MCNYFY2025 · Dec 31, 2025Research & Development
38.54MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
25.08MCNYFY2025 · Dec 31, 2025Other Operating Expenses
10.74MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
151.70KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
27.47MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0560CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0560CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.61BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.61BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-162.89MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
72.52MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-228.41MCNYFY2025 · Dec 31, 2025Free Cash Flow
-498.43MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
459.10MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-162.89MCNYFY2025 · Dec 31, 2025Other Non-cash Items
28.57MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-45.68MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-48.41MCNYFY2025 · Dec 31, 2025Capital Expenditures
-270.03MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-270.03MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
9.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-52.72MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.69MCNYFY2025 · Dec 31, 2025Other Financing Charges
1.14BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
1.09BCNYFY2025 · Dec 31, 2025